ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS Source: Eur Respir J 2007; 29: 482-488 Year: 2007
Effect of angiotensin converting enzyme (ACE) gene polymorphism on diaphragmatic endurance in neonates Source: Annual Congress 2008 - Neonatal intensive care: ventilation and beyond Year: 2008
The role of ACE insertion/deletion polymorphism in RDS development in neonates from Russia Source: Eur Respir J 2005; 26: Suppl. 49, 393s Year: 2005
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia Source: Eur Respir J 2008; 31: 611-617 Year: 2008
Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population Source: Eur Respir J 2006; 27: 1217-1222 Year: 2006
Activity and phenotypes of angiotensin-converting enzyme (ACE) in sarcoidosis with various organ involvement Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
Correlation between angiotensin-converting enzyme (ACE) gene polymorphism and exercise performance in COPD patients Source: Annual Congress 2010 - Exercise in COPD Year: 2010
Angiotensin-converting enzyme insertion/deletion polymorphism and risk and outcome of pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007
Impact of statins, angiotensin-converting enzyme inhibitors(ACEI), and angiotensin receptor blockers (ARBs) on reducing COPD morbidity Source: Annual Congress 2010 - COPD: management Year: 2010
Impact of statins, angiotensin-converting enzyme inhibitors (ACEI), and angiotensin receptor blockers (ARBS) on reducing COPD morbidity Source: Annual Congress 2009 - Treatment of airways disease Year: 2009
Respiratory function changes in patients with coronary heart disease after long-term treatment course by β-blockers and angiotensin-converting enzyme inhibitors Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004
Effect of long-term angiotensin-converting factor inhibitors on breathing function and hemorheology indices in patients with tuberculosis and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 306s Year: 2001
Association of circulating angiotensin converting enzyme activity with respiratory muscle function in infants Source: Annual Congress 2010 - Paediatric and neonatal intensive care Year: 2010
Alteration in angiotensin-converting enzyme 2 by PM1 during the development of emphysema in rats Source: ERJ Open Res, 6 (4) 00174-2020; 10.1183/23120541.00174-2020 Year: 2020
The association of angiotensin-converting enzyme gene insertion/deletion polymorphisms with OSA: a meta-analysis Source: Eur Respir J 2012; 40: 394-399 Year: 2012
Polymorphisms in angiotensin converting enzyme gene are associated with risk of development of and disease severity in scleroderma-related pulmonary arterial hypertension Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms Year: 2012
Serum angiotensin converting enzyme (ACE) as additional clinical markers of activity of pulmonary and extra-pulmonary locations of sarcoidosis Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders Year: 2011
Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia Source: Eur Respir J 2003; 22: 755-760 Year: 2003
Etiology specific reductions in pulmonary endothelial angiotensin converting enzyme activity in patients with PAH Source: Eur Respir J 2006; 28: Suppl. 50, 658s Year: 2006
Clinical significance of angiotensin converting enzyme (ACE) activity in sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 384s Year: 2001